Moreover, KALRN was downregulated in the heart tissue of patients affected by both DCM and ischemic cardiomyopathy [58], and mutations within KALRN have been associated with the promotion of stroke and coronary heart disease [56]. This evidence concerns the gene KALRN and coronary artery disorder.